InvestorsHub Logo
Followers 61
Posts 7519
Boards Moderated 2
Alias Born 02/10/2010

Re: None

Tuesday, 10/20/2015 3:57:09 PM

Tuesday, October 20, 2015 3:57:09 PM

Post# of 15662
I can't decide whether the information in today's PR Regarding receiving a positive opinion about Alferon getting a positive opinion by an EU body supporting an Orphan Designation use against MERS is a good thing,.... a massively indifferent thing,... or just pointless until all the other hoops down the line get done,....

http://seekingalpha.com/pr/15023206-hemispherx-biopharma-europe-n-v-s-a-receives-positive-opinion-on-application-for-orphan-designation-by-the-european-medicines-agency-for-alferon-n-injection-to-treat-patients-with-middle-east-respiratory-syndrome-mers

The Market appears to have viewed it is a bit of a positive,.... but no great shakes.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy